Home » Topics » Regulatory

Regulatory
RSS

Indications for Viread expanded in E.U.

May 29, 2003

Japanese sNDA submitted for Cleactor for acute pulmonary embolism

May 28, 2003

Seretide approved in E.U.

May 28, 2003

Valcyte completes European mutual recognition procedure for CMV prevention

May 27, 2003

Ventavis receives positive opinion in Europe

May 27, 2003

Extended-release alprazolam set for June launch

May 23, 2003

FDA approves Gleevec for Ph+ CML

May 23, 2003

First anti-TNF agent approved for ankylosing spondylitis in E.U.

May 22, 2003

Remicade approved in E.U. for maintenance therapy in Crohn's disease

May 22, 2003

Diabact licenses Rapinyl to Kyowa Hakko

May 20, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...